Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Viridian Therapeutics is raising $27,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Jonathan Violin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Viridian Therapeutics

Viridian Biosciences is strengthening the link between scientific discovery and product commercialization in the biopharmaceutical space.

To learn more about Viridian Therapeutics, visit http://www.viridianbio.com/

Contact:
Jonathan Violin, President and Chief Executive Officer
919-949-8552
https://www.linkedin.com/in/jonathan-violin-0a1bb21/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved